Federal grants to Biostrategies LC
Biostrategies LC in Jonesboro, Arkansas received $5.0 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), with $3.0 million. In fiscal 2025 it was awarded $1.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.0 million
- Awards6
- Awarded in FY 2025$1.5 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $390,497 |
| FY 2023 | 2 | $1.6 million |
| FY 2024 | 1 | $1.5 million |
| FY 2025 | 3 | $1.5 million |
Programs that fund Biostrategies LC
| Program | Awards | Amount |
|---|---|---|
| ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) | 1 | $3.0 million |
| 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies | 1 | $1.1 million |
| Vision Research | 1 | $350,000 |
| Child Health and Human Development Extramural Research | 1 | $295,923 |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $268,615 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $5.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Gene therapy that systemically produces brain-penetrating replacement enzyme for mps iiia (sanfilippo a syndrome) - project summary in this direct-to-phase II sbir, biostrategies lc proposes to advance the development of a novel aav- based gene therapy for mucopolysaccharidosis type iiia (mps iiia, | ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) | September 15, 2023 | $3.0 million |
| Treatment of GM1 gangliosidosis cns manifestations by aav systemic expression of lectin-enhanced enzyme - biostrategies lc proposes to complete ind-enabling studies to advance the development of BIOS-GM1, a novel drug therapy combining a delivery enhanced replacement enzyme with gene therapy to trea | 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies | September 15, 2025 | $1.1 million |
| Krabbe disease therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat pathologies of the cns - krabbe disease (globoid cell leukodystrophy) is a rare inherited disorder caused by a deficiency in the lysosomal enzyme galactosylceramidase (GALC) leading to destruction of the p | Extramural Research Programs in the Neurosciences and Neurological Disorders | July 5, 2022 | $390,497 |
| Treatment of GM1 gangliosidosis cns manifestations by aav systemic expression of lectin-enhanced enzyme - biostrategies lc proposes to complete ind-enabling studies to advance the development of BIOS-GM1, a novel drug therapy combining a delivery enhanced replacement enzyme with gene therapy to trea | Vision Research | September 19, 2025 | $350,000 |
| Morquio a therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat multisystemic clinical impairments of rare metabolic childhood diseases - mucopolysaccharidosis type iva (mps-iva; also called morquio a syndrome) is a rare genetic childhood disorder characterized by multi-sys | Child Health and Human Development Extramural Research | September 20, 2023 | $295,923 |
| Treatment of GM1 gangliosidosis cns manifestations by aav systemic expression of lectin-enhanced enzyme - biostrategies lc proposes to complete ind-enabling studies to advance the development of BIOS-GM1, a novel drug therapy combining a delivery enhanced replacement enzyme with gene therapy to trea | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 19, 2025 | $58,305 |
Questions people ask
How much federal grant money does Biostrategies LC get?
$5.0 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Biostrategies LC the most?
The Department of Health and Human Services, with $5.0 million in 6 awards.
What is Biostrategies LC's largest federal grant?
$3.0 million under ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), with its first action in the period on September 15, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Biostrategies LC?
Its largest are ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies and Vision Research.
Other grant recipients in Jonesboro
- Arkansas Early Learning
- Arkansas State University
- City of Jonesboro
- Jonesboro Urban Renewal & Housing Author
- Legal Aid of Arkansas Inc
- Craighead County
- Wesley at Jonesboro, Inc
- Northeast Arkansas Community Mental Health Center, Inc.
Largest federal grant recipients in Arkansas · Federal grants in Arkansas